Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults With SCD is a research paper published in American Journal of Hematology (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural NIH HHS
Grant: ZIA HL006211
The Cooperative Study of Late Effects for SCD Curative Therapies
Grant: 1U01HL156620-01
Intramural NIH HHS
Grant: Z99 HL999999
NHLBI NIH HHS
Grant: U01 HL156620
National Institutes of Health
Grant: 5U01HL156620-02
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
Clinical Center
CLC NIH HHS
Intramural Research Program of the NIH and National Heart, Lung, and Blood Institute
CLC NIH HHS
Intramural Research Program of the NIH and National Heart, Lung, and Blood Institute
FWCI
8.65
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Data for "Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults with SCD"
Data for "Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults with SCD"